The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Neuraxis Inc.(NYSE MKT:NRXS)


NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare ...
Website: https://neuraxis.com/
Founded: 2011
IPO Price: $6 (Aug 09, 2023)
Full Time Employees: 17
Sector: Biotechnology
Industry: Healthcare
Share this website to your friends
Neuraxis Days Payable Outstanding ttm (DPO)
Neuraxis Days Receivable Outstanding ttm (DSO)
Neuraxis Days Inventory Outstanding ttm (DIO)
Neuraxis Op Cashflow Per Share ttm
Neuraxis Free Cashflow Per Share ttm
Neuraxis Cash Per Share ttm
Neuraxis P/S ratio ttm
Neuraxis (GAAP) P/E ratio ttm
Neuraxis P/B ratio ttm
No extra charts and metrics for this ticker.